CCKBR and neoplasm: In the latter, mTORC1 inhibition by everolimus increased the level of CCKBR in the cancer cells and enhanced tumor-specific uptake of radiolabeled minigastrin [177Lu]Lu-PP-F11N in the A431/CCKBR xenograft nude mouse model.